HIV/AIDS, Severe Mental Illness and Homelessness



Status:Completed
Conditions:HIV / AIDS, Psychiatric
Therapuetic Areas:Immunology / Infectious Diseases, Psychiatry / Psychology
Healthy:No
Age Range:19 - Any
Updated:4/21/2016
Start Date:October 2010
End Date:January 2016

Use our guide to learn which trials are right for you!

This is a two-arm randomized controlled trial (RCT) for 308 seriously mentally ill adults
(SMI) engaging in risky sexual and/or drug use behavior, comparing a brief HIV primary and
secondary prevention intervention [Skills building and Motivational Interviewing (SB-MI) to
Care as Usual (CAU)]. The study setting is a large urban safety net Medical Center and
outcomes will be measured at 3, 6, and 12 months. The SB-MI intervention (3 sessions +
booster) was initially developed as the experimental condition in an R34 pilot project which
demonstrated its feasibility and promise. For the proposed project, the investigators will
recruit a larger sample which includes men and women with and without HIV, from various
ethnic and racial groups, sexual orientations and housing arrangements, as well as a range
of psychiatric disorders and functional capacities. In this way the investigators can more
rigorously demonstrate the promise of SB-MI with SMI. The investigators will also conduct a
sub-study after the 6 month follow-up to examine the impact at 12 months of an additional
booster session for SB-MI participants. The investigators specific aims are:

1. To examine the effectiveness of a brief, tailored primary and secondary risk reduction
strategy to CAU for people with serious mental illness. The desired outcomes include:

- Decreased frequency of risk behaviors (number of partners, number of encounters)

- Increased use of barrier precautions and IV needle cleaning

- Positive changes in information and motivation, as well as risk behaviors

- Increased HIV Counseling and Testing for those who do not know their HIV status

2. To examine the effectiveness of a 2nd booster session after the 6 month follow-up for ½
of participants randomized to SB-MI. The primary outcome will be:

- Decreased frequency of risk behaviors and increased use of barrier precautions at
the 12 month follow-up

Our long-term objective is to reduce the incidence of HIV risk behavior for SMI by
developing an intervention that can be easily translated and adapted to "real world"
settings. Our proposed project is designed to augment previously-developed research on HIV
risk reduction interventions for SMI. The innovations the investigators have developed
include: 1) SB-MI intervention design that can be utilized with diverse participants with SM
in contrast to other research which has focused on either primary or secondary prevention
with a fairly discrete population, such as women of color, patients in a drug recovery
program etc. The investigators will examine treatment response as a function of diverse
participant characteristics; 2) SB-MI intervention is delivered in an individual format to
provides a flexible structure for tailoring strategies and techniques for each participant's
complex cognitive and psychosexual functioning, as well as his/her needs and values in
contrast to research on HIV prevention in SMI which generally occurs in group and does not
allow for individualized tailoring. In addition, our experience with group interventions is
they do not easily allow for discussions of risk related to complex sexual and physical
abuse histories, sex trading and other stigmatized activities characteristic of SMI. Our
individualized approach affords maximum flexibility and privacy in selecting topics of
intervention, which the investigators also believe to be essential to the spirit of
Motivational Interviewing; 3) Previous interventions have typically been either very brief
(e.g. one half-hour session) or time-intensive. In contrast, our intervention (3 sessions +
1 or 2 Booster(s)) is long enough to allow participants to form a working alliance with
providers, but not so lengthy as to be burdensome or non-translatable for the real-world
settings in which patients routinely seek care such as urban safety net Medical Center's; 4)
a review of the literature suggests that many health behavior changes fade within a fairly
short period of time; our inclusion of booster session and a sub-study examining the effect
of a 2nd booster after the 6 month follow-up is a novel way of strengthening the effects of
our intervention. The investigators will also be extending our follow-up period to 12
months, to allow us to further assess long-term change; and 5) No study to date has examined
HIV counseling and testing as an outcome for this population (Senn & Carey, 2009). The
investigators believe this represents a significant deficit in attending to the needs of
SMI, given that testing and access to life-extending treatment should be an essential
component to prevention interventions for SMI. Both our SB-MI and CAU conditions will
include referrals for HIV testing where indicated, although the SB-MI intervention
systematically supports motivation for participants seeking HIV counseling and testing
services, whereas CAU provides information and general support for testing. The
investigators hope to see that the attention paid to this issue in SB-MI yields greater
access to HIV testing services.

Inclusion Criteria:

- Meet criteria for a serious mental illness (SMI)

- Engaged in HIV risk behavior during the previous 3 months

- Able to attend assessment and intervention appointments

- Have receptive and expressive English language skills sufficient for meaningful
participation

- Are 19 years of age or older.

- Capable of providing informed consent.

Exclusion Criteria:

- Unable to comprehend the assessment and/or intervention materials.

- Unable to provide independent consent and/or under a full guardianship.

- Do not meet criteria for a serious mental illness (SMI)

- Have not engaged in HIV risk behavior during the previous 3 months
We found this trial at
1
site
Boston, Massachusetts 02118
?
mi
from
Boston, MA
Click here to add this to my saved trials